AKT1 OVEREXPRESSION Detail (hg19) (AKT1)

Information

Genome

Assembly Position
hg19 chr14:105,235,686-105,262,096
hg38 chr14:104,769,349-104,795,759 View the variant detail on this assembly version.
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM
HGNC
Ensembl
NCBI
Gene Cards
OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
melanoma Vemurafenib D Predictive Does Not Support Resistance Somatic 3 24265155 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
An in vitro study of M229 (a human melanoma cell line) endogenously expressing wild-type AKT1 and BR... CIViC Evidence Detail
LY294002: PI3K inhibitor. Overexpression of AKT protects WM9 melanoma cells from apoptosis induced b... MMMP Detail
AG1478: EGFR inhibitor (tyrosine kinase receptor small molecule inhibitor). Overexpression of AKT pr... MMMP Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr14:105,235,686-105,262,096
Variant Type
cnv
Variant (CIViC) (CIViC Variant)
OVEREXPRESSION
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/2360
Genome browser